A placebo-controlled, parallel group multicenter phase III trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- 30 Mar 2017 New trial record
- 23 Mar 2017 According to a Futura Medical media release, the company expects initiation of this trial in the fourth quarter of 2017, completion of the trial in the fourth quarter of 2018 and regulatory submissions in the second quarter of 2019.
- 23 Mar 2017 According to a Futura Medical media release, the company is consulting with the UK and US regulatory authorities to finalize design and timing of this study.